Top compounds associated with response to MRPL39


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.15 2e-05
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.15 5e-05
mRNA niclosamide CTRPv2 pan-cancer AAC 0.15 5e-05
mRNA Gemcitabine gCSI pan-cancer AAC 0.23 5e-05
mRNA TW 37 GDSC1000 pan-cancer AAC 0.14 8e-05
mRNA Irinotecan CCLE pan-cancer AAC 0.21 9e-05
mRNA PD-0325901 GDSC1000 pan-cancer AAC -0.13 0.0002
mRNA Cisplatin GDSC1000 pan-cancer AAC 0.14 0.0002
mRNA VX-11e GDSC1000 pan-cancer AAC -0.13 0.0002
mRNA Topotecan CCLE pan-cancer AAC 0.16 0.0002
Download CSV